.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

AMERGE Drug Profile

« Back to Dashboard

Which patents cover Amerge, and what substitute generic drugs are available?

Amerge is a drug marketed by Glaxosmithkline Llc and is included in one NDA.

The generic ingredient in AMERGE is naratriptan hydrochloride. There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the naratriptan hydrochloride profile page.

Summary for Tradename: AMERGE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list87
Clinical Trials: see list1
Patent Applications: see list2,467
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMERGE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Llc
AMERGE
naratriptan hydrochloride
TABLET;ORAL020763-002Feb 10, 1998RXYesNo► Subscribe► Subscribe
Glaxosmithkline Llc
AMERGE
naratriptan hydrochloride
TABLET;ORAL020763-001Feb 10, 1998RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: AMERGE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc
AMERGE
naratriptan hydrochloride
TABLET;ORAL020763-002Feb 10, 19984,997,841► Subscribe
Glaxosmithkline Llc
AMERGE
naratriptan hydrochloride
TABLET;ORAL020763-001Feb 10, 19984,997,841► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc